I graduated in Economics from the University of Salerno (Italy) in 2012 and then completed a Masters in Statistics at the University of Bologna (Italy) in 2014.
I joined the Cancer Survival Group in 2015 and I’m working in the CONCORD programme since then.
In 2018, I also started a part-time PhD aiming to explain global variation in population-based survival from malignant melanoma.
I joined the Cancer Survival Group in 2015 and I’m working in the CONCORD programme since then.
In 2018, I also started a part-time PhD aiming to explain global variation in population-based survival from malignant melanoma.
Affiliations
Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health
Teaching
Statistical Methods in Epidemiology (2402)
Statistics for EPH (2402),
Cancer survival: principles, methods and analysis (short course)
Statistics for EPH (2402),
Cancer survival: principles, methods and analysis (short course)
Research
My main research interests are in international comparisons of population-based cancer survival, which are designed to measure the comparative effectiveness of health systems in cancer control, and thus to influence cancer control policy.
I'm particularly interested in explaining the wide global variation in population-based survival from malignant melanoma in countries partecipating in the CONCORD programme.
I am part of the CONCORD and VENUSCANCER Central Analytic Team. VENUSCANCER is a high-resolution study aiming at explaining the reasons for world-wide disparities in survival for women's cancer by looking at detailed information on tumour biology, stage, staging procedures, treatments and socio-economic variables.
I’m also involved in the modelling of life tables for countries participating in the CONCORD study by applying a new multivariable, flexible model developed in the Cancer Survival Group to estimate complete, smoothed life tables for sub-national populations.
I'm particularly interested in explaining the wide global variation in population-based survival from malignant melanoma in countries partecipating in the CONCORD programme.
I am part of the CONCORD and VENUSCANCER Central Analytic Team. VENUSCANCER is a high-resolution study aiming at explaining the reasons for world-wide disparities in survival for women's cancer by looking at detailed information on tumour biology, stage, staging procedures, treatments and socio-economic variables.
I’m also involved in the modelling of life tables for countries participating in the CONCORD study by applying a new multivariable, flexible model developed in the Cancer Survival Group to estimate complete, smoothed life tables for sub-national populations.
Selected Publications
Fairer breast cancer in a globalised world
2023
World-wide availability of high-resolution data for breast cancer: the VENUSCANCER project.
2023
World-wide trends in patterns of care for breast, cervical and ovarian cancers – The VENUSCANCER project
2023
Evaluation of cancer outcomes: international perspectives
2023
Women’s cancers: do variations in patterns of care explain the world-wide inequalities in survival and avoidable premature death?
2022
